RESEARCH USE ONLY · NOT FOR HUMAN OR ANIMAL CONSUMPTION · 21+ ONLY
Login required. Manage anytime from Account → Subscriptions.
on orders over $200
plain and unbranded packaging
256-bit SSL
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥ & 99% |
| Form | Lyophilized powder |
-20°C 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | Cagrilintide 10mg |
|---|---|
| Lot # | CGL0001 |
| Labeled | 10mg |
| Actual | 10.37mg |
| Tested | Jul 24, 2026 |
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025
DOI: 10.1056/NEJMoa2502081
· Garvey WT, Blücher M, Osorto Contreras CK et al.
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2021
PMID: 34798060
· Lau DCW et al.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial
2021
PMID: 33894838
· Enebo LB et al.
Lumera BioLabs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
Not a researcher? Exit
